Kolexia
Watier Herve
Biologie médicale
Centre hospitalier de Tours
Tours, France
104 Activités
101 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Polyarthrite rhumatoïde Arthrite Tumeurs colorectales Spondylarthrite Anaphylaxie Métastase tumorale Tumeurs du côlon Rhumatismes Tumeurs du rectum

Industries

Lilly
9 collaboration(s)
Dernière en 2022
Zeste Research
2 collaboration(s)
Dernière en 2021
AstraZeneca
2 collaboration(s)
Dernière en 2023
Alexion
1 collaboration(s)
Dernière en 2021

Dernières activités

Albumin influences leucocyte FcRn expression in the early days of kidney transplantation.
Clinical and experimental immunology   13 février 2024
Why is there no biosimilar of Erbitux®?
Journal of pharmaceutical and biomedical analysis   22 juin 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
mAbs   16 mai 2023
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis   08 mai 2023
Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods.
International journal of molecular sciences   16 mars 2023
Finding the Right Heavy Chains for Immunostimulatory Antibodies.
International journal of molecular sciences   08 septembre 2022
A New in Silico Antibody Similarity Measure Both Identifies Large Sets of Epitope Binders with Distinct CDRs and Accurately Predicts Off-Target Reactivity.
International journal of molecular sciences   28 août 2022
Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review.
International journal of molecular sciences   24 août 2022
How has the future investment program stimulated research and innovation in health?
Therapie   18 janvier 2022
Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?
Therapie   12 janvier 2022